Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
Zacks Investment Research on MSN1d
GILD Data on Once-Yearly Lenacapavir for HIV Prevention PositiveGilead Sciences, Inc. GILD announced positive data from its ongoing phase I study evaluating pipeline candidate, lenacapavir.
The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center, collaborates with researchers from the Kenya Medical Research Institute ...
| Real-world evidence lets us see how HIV medicines work in real life, helping HCPs provide better care and improving ...
Lynae Darbes, PhD, presented research on the effectiveness of a home-based intervention for HIV prevention among couples ...
AllAfrica on MSN3h
CS Barasa Flags Off ARV Consignment, Assures of Uninterrupted HIV CareHealth Cabinet Secretary Deborah Barasa has reaffirmed Kenya's dedication to providing uninterrupted care for individuals living with HIV, despite recent challenges stemming from a freeze in foreign ...
Disparities in HIV diagnosis rates were observed between Black and White individuals in the US from 2017 to 2021.
News Medical on MSN2d
Gaps in HPV cancer screening and prevention identified for people living with HIVA new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback